LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Lapatinib | 10 | uM | LJP6 | 3 | M19 | 72 | hr | 1311 | 3516 | 4973 | 0.7069 | 0.6699 |
MDA-MB-231 | Sirolimus | 0.04 | uM | LJP6 | 1 | L18 | 72 | hr | 1311 | 4577 | 4870 | 0.9398 | 0.9354 |
MDA-MB-231 | Sirolimus | 0.04 | uM | LJP6 | 2 | L18 | 72 | hr | 1311 | 3899 | 4961 | 0.7858 | 0.7640 |
MDA-MB-231 | Sirolimus | 0.04 | uM | LJP6 | 3 | L18 | 72 | hr | 1311 | 4308 | 4973 | 0.8661 | 0.8560 |
MDA-MB-231 | Sirolimus | 0.12 | uM | LJP6 | 1 | L17 | 72 | hr | 1311 | 4267 | 4870 | 0.8761 | 0.8650 |
MDA-MB-231 | Sirolimus | 0.12 | uM | LJP6 | 2 | L17 | 72 | hr | 1311 | 3920 | 4961 | 0.7901 | 0.7689 |
MDA-MB-231 | Sirolimus | 0.12 | uM | LJP6 | 3 | L17 | 72 | hr | 1311 | 4261 | 4973 | 0.8567 | 0.8454 |
MDA-MB-231 | Sirolimus | 0.37 | uM | LJP6 | 1 | L16 | 72 | hr | 1311 | 4414 | 4870 | 0.9063 | 0.8987 |
MDA-MB-231 | Sirolimus | 0.37 | uM | LJP6 | 2 | L16 | 72 | hr | 1311 | 3921 | 4961 | 0.7903 | 0.7692 |
MDA-MB-231 | Sirolimus | 0.37 | uM | LJP6 | 3 | L16 | 72 | hr | 1311 | 4415 | 4973 | 0.8877 | 0.8798 |
MDA-MB-231 | Sirolimus | 1.11 | uM | LJP6 | 1 | L15 | 72 | hr | 1311 | 4244 | 4870 | 0.8714 | 0.8597 |
MDA-MB-231 | Sirolimus | 1.11 | uM | LJP6 | 2 | L15 | 72 | hr | 1311 | 3939 | 4961 | 0.7939 | 0.7734 |
MDA-MB-231 | Sirolimus | 1.11 | uM | LJP6 | 3 | L15 | 72 | hr | 1311 | 4359 | 4973 | 0.8764 | 0.8674 |
MDA-MB-231 | Sirolimus | 3.33 | uM | LJP6 | 1 | L14 | 72 | hr | 1311 | 4362 | 4870 | 0.8957 | 0.8869 |
MDA-MB-231 | Sirolimus | 3.33 | uM | LJP6 | 2 | L14 | 72 | hr | 1311 | 4048 | 4961 | 0.8159 | 0.7988 |
MDA-MB-231 | Sirolimus | 3.33 | uM | LJP6 | 3 | L14 | 72 | hr | 1311 | 4369 | 4973 | 0.8784 | 0.8696 |
MDA-MB-231 | Sirolimus | 10 | uM | LJP6 | 1 | L13 | 72 | hr | 1311 | 4361 | 4870 | 0.8954 | 0.8866 |
MDA-MB-231 | Sirolimus | 10 | uM | LJP6 | 2 | L13 | 72 | hr | 1311 | 4148 | 4961 | 0.8360 | 0.8218 |
MDA-MB-231 | Sirolimus | 10 | uM | LJP6 | 3 | L13 | 72 | hr | 1311 | 4388 | 4973 | 0.8822 | 0.8738 |
MDA-MB-231 | ZSTK474 | 0.04 | uM | LJP6 | 1 | M18 | 72 | hr | 1311 | 4617 | 4870 | 0.9480 | 0.9444 |
MDA-MB-231 | ZSTK474 | 0.04 | uM | LJP6 | 2 | M18 | 72 | hr | 1311 | 4265 | 4961 | 0.8596 | 0.8484 |
MDA-MB-231 | ZSTK474 | 0.04 | uM | LJP6 | 3 | M18 | 72 | hr | 1311 | 4439 | 4973 | 0.8925 | 0.8851 |
MDA-MB-231 | ZSTK474 | 0.12 | uM | LJP6 | 1 | M17 | 72 | hr | 1311 | 4259 | 4870 | 0.8745 | 0.8632 |
MDA-MB-231 | ZSTK474 | 0.12 | uM | LJP6 | 2 | M17 | 72 | hr | 1311 | 3899 | 4961 | 0.7858 | 0.7640 |
MDA-MB-231 | ZSTK474 | 0.12 | uM | LJP6 | 3 | M17 | 72 | hr | 1311 | 4382 | 4973 | 0.8810 | 0.8725 |